Remove pharmaceutical-engineering section technical
article thumbnail

New EU AI Regulation and GAMP® 5

ISPE

AI Technical Documentation and GAMP ® 5 In GAMP® 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition) 2 , Article 11 1 describes the technical documentation needed. Main section chapter 7.12 Main section chapter 7.12

article thumbnail

Enabling Global Pharma Innovation: Delivering for Patients

ISPE

The scope includes innovations in modalities, modes of delivery and administration of medicines, pharmaceutical manufacturing and analytical technology, and digital transformation. Addressing divergence in global regulatory expectations is imperative to improve the advancement of pharmaceutical and technological innovation.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

Postapproval change management of pharmaceuticals is an essential part of life-cycle management but is associated with regulatory challenges. In an attempt to address these challenges, in 2019 the ICH endorsed ICH Q12, Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management (and Annexes).

article thumbnail

ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma

ISPE

ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma Trudy Patterson Mon, 07/10/2023 - 15:37 Technical July / August 2023 ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma Martin Heitmann, FRM Stefan MÜNCH Brandi M. Specific aspects of pharmaceutical roles (e.g.,

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Watson, PhD 1 May 2023 When working with the common technical dossier (CTD), the structure of Module 2 “follows the scope and outline of the Body of Data in Module 3,” 1 which can reduce review efficiency. 3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Brown Megan E.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Watson, PhD 29 March 2023 When working with the common technical dossier (CTD), the structure of Module 2 “follows the scope and outline of the Body of Data in Module 3,” 1 which can reduce review efficiency. 3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Brown Megan E.

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

Firmino 1 May 2023 The global pandemic has demonstrated that now, more than ever, we need to work toward a global solution and prioritize the harmonization of technical requirements. Table 1: Appendices and drug substance Module 3 required sections * Corresponding Quality Overall Summaries (QOS) sections 2.3.S.1, 6, and 2.3.S.7